URINEUTRAL

URI PEG Ratio Analysis

1.20x

Updated 201h ago·SEC filings & market data

Key Takeaway

The PEG ratio (price/earnings-to-growth) of 1.25x means the stock’s price is about 25% higher than its earnings growth rate would justify, so it is moderately valued for its expected growth.

Sector Performance

60th percentile

URI

1.20x

Sector Median

0.77x

Sector Avg

2.65x

Prior Period

1.25x(Aug 2026)

↑ Improving

📊

Deep Analysis

The PEG ratio (price/earnings-to-growth) of 1.25x means the stock’s price is about 25% higher than its earnings growth rate would justify, so it is moderately valued for its expected growth.

For context, the sector median is 0.81x, placing URI at the 61st percentile among peers — meaning it is priced above the typical sector stock. The metric is decreasing: quarter-over-quarter it fell 3.8%, while the year-over-year change is N/A; the last four values (1.25x, 1.30x, 10.65x, 10.86x) show a sharp drop from earlier extremes. A lower PEG over time reduces valuation risk, but at 1.25x the stock still carries more premium than half its sector. This combination suggests improving affordability relative to growth, though not a bargain. The decreasing trend supports the NEUTRAL verdict by softening the valuation concern without making the stock clearly undervalued.